Literature DB >> 23725656

Human dendritic cell subsets in vaccination.

Karolina Palucka1, Jacques Banchereau.   

Abstract

Owing to their properties, dendritic cells (DCs) are often called 'nature's adjuvants' and thus have become the natural targets for antigen delivery. DCs provide an essential link between the innate and the adaptive immune responses. DCs are at the center of the immune system owing to their ability to control both tolerance and immunity. DCs are thus key targets for both preventive and therapeutic vaccination. Herein, we will discuss recent progresses in our understanding of DC subsets physiology as it applies to vaccination.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23725656      PMCID: PMC3711217          DOI: 10.1016/j.coi.2013.05.001

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  91 in total

Review 1.  Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination.

Authors:  Christophe J Desmet; Ken J Ishii
Journal:  Nat Rev Immunol       Date:  2012-06-22       Impact factor: 53.106

2.  Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype.

Authors:  Mireille H Lahoud; Fatma Ahmet; Susie Kitsoulis; Soo San Wan; David Vremec; Chin-Nien Lee; Belinda Phipson; Wei Shi; Gordon K Smyth; Andrew M Lew; Yu Kato; Scott N Mueller; Gayle M Davey; William R Heath; Ken Shortman; Irina Caminschi
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

3.  CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis.

Authors:  C Caux; C Massacrier; B Vanbervliet; B Dubois; I Durand; M Cella; A Lanzavecchia; J Banchereau
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

Review 4.  The design and evaluation of HIV-1 vaccines.

Authors:  Kevin O Saunders; Rebecca S Rudicell; Gary J Nabel
Journal:  AIDS       Date:  2012-06-19       Impact factor: 4.177

5.  HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ.

Authors:  Anupama Sharma; Ursula Koldovsky; Shuwen Xu; Rosemarie Mick; Robert Roses; Elizabeth Fitzpatrick; Susan Weinstein; Harvey Nisenbaum; Bruce L Levine; Kevin Fox; Paul Zhang; Gary Koski; Brian J Czerniecki
Journal:  Cancer       Date:  2012-01-17       Impact factor: 6.860

6.  Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells.

Authors:  Eynav Klechevsky; Rimpei Morita; Maochang Liu; Yanying Cao; Sebastien Coquery; Luann Thompson-Snipes; Francine Briere; Damien Chaussabel; Gerard Zurawski; A Karolina Palucka; Yoram Reiter; Jacques Banchereau; Hideki Ueno
Journal:  Immunity       Date:  2008-09-19       Impact factor: 31.745

Review 7.  Dendritic cell vaccination in autoimmune disease.

Authors:  Catharina C Gross; Heinz Wiendl
Journal:  Curr Opin Rheumatol       Date:  2013-03       Impact factor: 5.006

8.  Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells.

Authors:  Dapeng Li; Gabrielle Romain; Anne-Laure Flamar; Dorothée Duluc; Melissa Dullaers; Xiao-Hua Li; Sandra Zurawski; Nathalie Bosquet; Anna Karolina Palucka; Roger Le Grand; Anne O'Garra; Gerard Zurawski; Jacques Banchereau; Sangkon Oh
Journal:  J Exp Med       Date:  2012-01-02       Impact factor: 14.307

9.  Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis.

Authors:  Audrey Le Floc'h; Abdelali Jalil; Isabelle Vergnon; Béatrice Le Maux Chansac; Vladimir Lazar; Georges Bismuth; Salem Chouaib; Fathia Mami-Chouaib
Journal:  J Exp Med       Date:  2007-02-26       Impact factor: 14.307

10.  BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction.

Authors:  A Dzionek; Y Sohma; J Nagafune; M Cella; M Colonna; F Facchetti; G Günther; I Johnston; A Lanzavecchia; T Nagasaka; T Okada; W Vermi; G Winkels; T Yamamoto; M Zysk; Y Yamaguchi; J Schmitz
Journal:  J Exp Med       Date:  2001-12-17       Impact factor: 14.307

View more
  29 in total

1.  The Efficacy of CIK-Based Immunotherapies for Advanced Solid Tumors.

Authors:  Hongjin Chu; Fengcai Du; Lixin Jiang; Zhixin Wang; Zhaohua Gong; Peiwen Lian; Peng Li; Jian Chen
Journal:  Technol Cancer Res Treat       Date:  2016-07-19

Review 2.  Collaboration of Toll-like and RIG-I-like receptors in human dendritic cells: tRIGgering antiviral innate immune responses.

Authors:  Attila Szabo; Eva Rajnavolgyi
Journal:  Am J Clin Exp Immunol       Date:  2013-10-16

Review 3.  Neonatal Vaccination: Challenges and Intervention Strategies.

Authors:  Matthew C Morris; Naveen Surendran
Journal:  Neonatology       Date:  2016-01-13       Impact factor: 4.035

4.  Vaccine delivery by penetratin: mechanism of antigen presentation by dendritic cells.

Authors:  Dodie Pouniotis; Choon-Kit Tang; Vasso Apostolopoulos; Geoffrey Pietersz
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

5.  Immunomodulatory Functions of BTLA and HVEM Govern Induction of Extrathymic Regulatory T Cells and Tolerance by Dendritic Cells.

Authors:  Andrew Jones; Jessica Bourque; Lindsey Kuehm; Adeleye Opejin; Ryan M Teague; Cindy Gross; Daniel Hawiger
Journal:  Immunity       Date:  2016-10-25       Impact factor: 31.745

6.  Delineation of a novel dendritic-like subset in human spleen.

Authors:  Sawang Petvises; Dipti Talaulikar; Helen C O'Neill
Journal:  Cell Mol Immunol       Date:  2015-04-20       Impact factor: 11.530

7.  GK1 Improves the Immune Response Induced by Dendritic Cells of BALB/c Mice Infected with Leishmania mexicana Promastigotes.

Authors:  Laila Gutiérrez-Kobeh; Arturo A Wilkins-Rodríguez
Journal:  Acta Parasitol       Date:  2019-09-30       Impact factor: 1.440

8.  Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients.

Authors:  R Oostvogels; E Kneppers; M C Minnema; R C Doorn; L E Franssen; T Aarts; M E Emmelot; E Spierings; I Slaper-Cortenbach; K Westinga; E Goulmy; H M Lokhorst; T Mutis
Journal:  Bone Marrow Transplant       Date:  2016-11-14       Impact factor: 5.483

Review 9.  Trial watch: Dendritic cell-based anticancer therapy.

Authors:  Norma Bloy; Jonathan Pol; Fernando Aranda; Alexander Eggermont; Isabelle Cremer; Wolf Hervé Fridman; Jitka Fučíková; Jérôme Galon; Eric Tartour; Radek Spisek; Madhav V Dhodapkar; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-12-21       Impact factor: 8.110

10.  Nanoparticle-mediated combinatorial targeting of multiple human dendritic cell (DC) subsets leads to enhanced T cell activation via IL-15-dependent DC crosstalk.

Authors:  Kartik Sehgal; Ragy Ragheb; Tarek M Fahmy; Madhav V Dhodapkar; Kavita M Dhodapkar
Journal:  J Immunol       Date:  2014-07-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.